Novartis AG (NVSEF)
96.46
+0.14
(+0.14%)
USD |
OTCM |
Jan 06, 16:00
Novartis Profit Margin (Quarterly): 24.21% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AC Immune SA | 21.59% |
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | -2.84K% |
| NLS Pharmaceutics Ltd | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 41.89% |
| Return on Assets | 17.33% |
| Return on Invested Capital | 25.80% |
| Gross Profit Margin (Quarterly) | 75.45% |
| Operating Margin (Quarterly) | 27.54% |
| Return on Net Operating Assets | 22.97% |